Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients

Launched by UNIVERSITY OF FLORIDA · Feb 8, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help young heart transplant recipients take their medication regularly. The study is called Mobile Video Directly Observed Therapy (eMocha DOT) and aims to improve how well these patients follow their medication schedule. This is important because not taking the medication as prescribed can lead to serious health problems, including the risk of heart rejection, more hospital visits, or even life-threatening issues.

To participate in this study, individuals must be between 10 and 21 years old, have received a heart transplant, and be able to use a smartphone or other devices to access the mobile app. They should also be willing to communicate through the app and have had some challenges with medication adherence in the past. Participants will be randomly assigned to either use the eMocha DOT program or continue with usual care, and they can expect to receive support and reminders to help them stay on track with their medications. This trial is currently recruiting participants and hopes to make a meaningful impact on the health of young heart transplant patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Eligible participants are 10-21 years of age
• • Have received a heart transplant and are followed participating pediatric heart transplant centers
• • English-speaking or Spanish-speaking
• • Own a smart-phone or have access to the mobile app through other devices
• • Are willing to receive information through it
• • Have a MLVI score of greater than 2.0 over the last year
• Exclusion Criteria:
• • • Those with cognitive impairments will not be eligible for enrollment due to inability to provide informed assent